Martech Medical Products appears in FDA device records as the applicant for a single premarket notification in the linked collection: K254095, a 25G Huber Needle cleared as substantially equivalent on September 18, 2026. The FDA 510(k) record lists the applicant at 1500 Delp Dr., Harleysville, Pennsylvania, and identifies the device as a non-coring (Huber) needle in Class II, regulation 880.5570, product code PTI. That address is a filing address, not a verified headquarters. Separately, the manufacturer’s published About page states the company was founded in 1978 and describes concept-to-production services for medical device companies. [1][2][6]
The K254095 clearance and its device identity
The FDA 510(k) database entry for K254095 names Martech Medical Products as applicant, with a decision date of September 18, 2026, decision code SESE and the description “Substantially Equivalent.” The record carries product code PTI, device class 2, regulation number 880.5570 and the openFDA device name “Non-Coring (Huber) Needle,” with the advisory committee listed as General Hospital. The same record gives a date received of December 19, 2025 and a clearance type of Traditional, with a third-party flag of N. [1]
The FDA clearance letter for K254095, dated September 18, 2026 and addressed to Ashley Rolfe, Corporate Manager of Regulatory Affairs, identifies the trade/device name as 25G Huber Needle and restates regulation 21 CFR 880.5570, Hypodermic Single Lumen Needle, Class II, product code PTI. The letter’s dated and received fields read August 17, 2026 and August 18, 2026, which differ from the December 19, 2025 receipt date in the database entry; the records do not reconcile the two, and the letter does not state whether its dates refer to an amendment. [2]
Documented components in the filing
The clearance letter’s enclosure lists device components and accessories by name: protector tubing, extension clamps, female Luer fitting, flexible double wings, hub, needleless connector, ID ring, non-coring needle, needle cap, PVC tubing extension, male Luer cap, hub/casing, Y needleless adapters and Y-needle adapters. These are the part names as printed in the FDA letter; the record does not assign materials, dimensions or performance specifications to individual components beyond the PVC tubing extension. [2]
A separate FDA establishment registration and device listing page for product code PTI shows the proprietary name PRO-LOCK CT SAFETY INFUSION under the classification name NON-CORING (HUBER) NEEDLE, device class 2, regulation 880.5570. That listing is a distinct FDA record from the K254095 clearance and does not establish that the listed product is the device cleared under K254095. [8]
Registration status and the applicant’s own description
FDA establishment registration records list MARTECH MEDICAL PRODUCTS at 1500 Delp Dr., Harleysville, PA 19438, registration number 2527072, FEI number 2527072, status Active, with the firm marked as an initial distributor/importer and a registration status date of 2026. The same page names the owner/operator as Martech Medical Products and the official correspondent as Daryl Clark. A search by owner/operator number 2527072 returns two results, which is a count of registration rows, not of products or clearances. [4][7]
The manufacturer’s published About page states that Martech was founded in 1978 and was known as a supplier of extrusions and molded components, growing through work that included designing and manufacturing small epidural catheters and hemodialysis catheters. The same page describes concept-to-production services and support for medical device companies and refers to three manufacturing and engineering facilities, over 2,000 employees and a Mexicali, B.C., Mexico location. The company’s homepage states a vision and mission of being a solution provider for every customer served and describes in-house tool design and fabrication with customization of the existing product line. [6][5]
What the linked collection does and does not show
The linked FDA collection for this company contains one record, a 510(k) under K254095, and one decision, SESE; the smaller record sample likewise contains that single 510(k) and one SESE decision. These counts describe the filings retrieved as of November 20, 2026 and are not measures of total company sales, total portfolio or safety performance. No recall records appear in the retrieved sample. [1]
The records do not identify a parent company, brand ownership, customers or commercial availability of the 25G Huber Needle, and the manufacturer’s pages do not state a corporate headquarters. The Harleysville address appears in FDA filings and registration records; treating it as headquarters would exceed what those documents say. [1][4][6]

